LFB works for « the France of tomorrow » and unveils a new industrial project in Alès
LFB research Grant in Immunology 2021 is open for applications
THE LFB IS COMMITTED TO THE MANAGEMENT OF SEVERE BLEEDING AT THE E-SFAR 2021 CONGRES
EMA acceptance for filing of the MARKETING AUTHORISATION application FOR EPTACOG BETA, THE LFB RECOMBINANT FACTOR VIIA , AND PUBLICATION OF THE EXPLORATORY IN VITRO STUDY RESULTS on eptacog beta in combination with emicizumab
LFB is committed to patients suffering from rare coagulation disorders at GTH Congress 2021.
LFB is committed to Von Willebrand disease at EAHAD 2021
LFB 2021 corporate Brochure
Take a look at the new LFB corporate brochure!